These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 26515103)

  • 1. Brivaracetam augments short-term depression and slows vesicle recycling.
    Yang X; Bognar J; He T; Mohammed M; Niespodziany I; Wolff C; Esguerra M; Rothman SM; Dubinsky JM
    Epilepsia; 2015 Dec; 56(12):1899-909. PubMed ID: 26515103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seletracetam enhances short term depression in vitro.
    Yang X; Meehan AL; Rothman SM; Dubinsky JM
    Epilepsy Res; 2015 Nov; 117():17-22. PubMed ID: 26320080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brivaracetam Modulates Short-Term Synaptic Activity and Low-Frequency Spontaneous Brain Activity by Delaying Synaptic Vesicle Recycling in Two Distinct Rodent Models of Epileptic Seizures.
    Xing H; Han X; Xu S; Sun Z; Yang S
    J Mol Neurosci; 2022 May; 72(5):1058-1074. PubMed ID: 35278193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a differential interaction of brivaracetam and levetiracetam with the synaptic vesicle 2A protein.
    Wood MD; Gillard M
    Epilepsia; 2017 Feb; 58(2):255-262. PubMed ID: 28012162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levetiracetam accelerates the onset of supply rate depression in synaptic vesicle trafficking.
    García-Pérez E; Mahfooz K; Covita J; Zandueta A; Wesseling JF
    Epilepsia; 2015 Apr; 56(4):535-45. PubMed ID: 25684406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged exposure to levetiracetam reveals a presynaptic effect on neurotransmission.
    Yang XF; Weisenfeld A; Rothman SM
    Epilepsia; 2007 Oct; 48(10):1861-9. PubMed ID: 17521346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brivaracetam, a selective high-affinity synaptic vesicle protein 2A (SV2A) ligand with preclinical evidence of high brain permeability and fast onset of action.
    Nicolas JM; Hannestad J; Holden D; Kervyn S; Nabulsi N; Tytgat D; Huang Y; Chanteux H; Staelens L; Matagne A; Mathy FX; Mercier J; Stockis A; Carson RE; Klitgaard H
    Epilepsia; 2016 Feb; 57(2):201-9. PubMed ID: 26663401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levetiracetam has an activity-dependent effect on inhibitory transmission.
    Meehan AL; Yang X; Yuan LL; Rothman SM
    Epilepsia; 2012 Mar; 53(3):469-76. PubMed ID: 22292611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Favorable adverse effect profile of brivaracetam vs levetiracetam in a preclinical model.
    Sanon NT; Gagné J; Wolf DC; Aboulamer S; Bosoi CM; Simard A; Messiet E; Desgent S; Carmant L
    Epilepsy Behav; 2018 Feb; 79():117-125. PubMed ID: 29287214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further evidence for a differential interaction of brivaracetam and levetiracetam with the synaptic vesicle 2A protein.
    Wood MD; Sands ZA; Vandenplas C; Gillard M
    Epilepsia; 2018 Sep; 59(9):e147-e151. PubMed ID: 30144048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levetiracetam inhibits endocytosis and augments short-term depression.
    Pharmazie; 2018 Nov; 73(11):643-646. PubMed ID: 30396382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brivaracetam does not modulate ionotropic channels activated by glutamate, γ-aminobutyric acid, and glycine in hippocampal neurons.
    Niespodziany I; Rigo JM; Moonen G; Matagne A; Klitgaard H; Wolff C
    Epilepsia; 2017 Nov; 58(11):e157-e161. PubMed ID: 28850675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new mechanism for antiepileptic drug action: vesicular entry may mediate the effects of levetiracetam.
    Meehan AL; Yang X; McAdams BD; Yuan L; Rothman SM
    J Neurophysiol; 2011 Sep; 106(3):1227-39. PubMed ID: 21653714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brivaracetam Prevents the Over-expression of Synaptic Vesicle Protein 2A and Rescues the Deficits of Hippocampal Long-term Potentiation In Vivo in Chronic Temporal Lobe Epilepsy Rats.
    Ge YX; Lin YY; Bi QQ; Chen YJ
    Curr Neurovasc Res; 2020; 17(4):354-360. PubMed ID: 32407277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brivaracetam: Rationale for discovery and preclinical profile of a selective SV2A ligand for epilepsy treatment.
    Klitgaard H; Matagne A; Nicolas JM; Gillard M; Lamberty Y; De Ryck M; Kaminski RM; Leclercq K; Niespodziany I; Wolff C; Wood M; Hannestad J; Kervyn S; Kenda B
    Epilepsia; 2016 Apr; 57(4):538-48. PubMed ID: 26920914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single-center, open-label positron emission tomography study to evaluate brivaracetam and levetiracetam synaptic vesicle glycoprotein 2A binding in healthy volunteers.
    Finnema SJ; Rossano S; Naganawa M; Henry S; Gao H; Pracitto R; Maguire RP; Mercier J; Kervyn S; Nicolas JM; Klitgaard H; DeBruyn S; Otoul C; Martin P; Muglia P; Matuskey D; Nabulsi NB; Huang Y; Kaminski RM; Hannestad J; Stockis A; Carson RE
    Epilepsia; 2019 May; 60(5):958-967. PubMed ID: 30924924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714), a high-affinity ligand for the synaptic vesicle protein, SV2A.
    Matagne A; Margineanu DG; Kenda B; Michel P; Klitgaard H
    Br J Pharmacol; 2008 Aug; 154(8):1662-71. PubMed ID: 18500360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brivaracetam efficacy and safety in focal epilepsy.
    Makke Y; Abou-Khalil B
    Expert Rev Neurother; 2019 Oct; 19(10):955-964. PubMed ID: 31195850
    [No Abstract]   [Full Text] [Related]  

  • 19. Brivaracetam (ucb 34714) inhibits Na(+) current in rat cortical neurons in culture.
    Zona C; Pieri M; Carunchio I; Curcio L; Klitgaard H; Margineanu DG
    Epilepsy Res; 2010 Jan; 88(1):46-54. PubMed ID: 19914041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerability, efficacy and retention rate of Brivaracetam in patients previously treated with Levetiracetam: A monocenter retrospective outcome analysis.
    Hirsch M; Hintz M; Specht A; Schulze-Bonhage A
    Seizure; 2018 Oct; 61():98-103. PubMed ID: 30118932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.